FDA Clearance for 23andMe genetic test on Hereditary Prostate Cancer Marker
The clearance allows 23andMe to report on the G84E mutation in the HOXB13 gene, clinically shown to significantly increase the risk of developing pros…
Tag: Innovation
Spotlight on: Frontiers Health 2021
Digital health is unlocking new avenues for innovation across life sciences, and industry leaders are keen to tap into the potential of this burgeonin…
Elizabeth Holmes: between a drop and a hard place
Business ethics lessons in the Digital Health care start-up culture Once considered by Forbes “the world's youngest self-made woman billionaire”, E…
23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”), a leading consumer genetics and research company, today announced…
Pear Therapeutics goes public on Nasdaq as Pear
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines,…
Pear Therapeutics receives FDA Breaktrough Device Designation
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…
Can Digital Health care be sustainable?
We have written not long ago that Big Data is revolutionizing the health care delivery systems, increased by the omnipresence of digital dev…
Global Health & Wellbeing Coaching Symposium
Join YourCoach.Health for their second annual Global Health & Wellness Coaching Symposium on November 17-19, 2021. The event will be offered at…
Novel algorithm on wearable devices can detect irregular heartbeat, may prompt early care
Research Highlights: A novel software algorithm developed for wearable devices, such as smartwatches and fitness trackers, was able to detect irreg…
How the use of Virtual Reality (VR) can be benefitial in treatments for Chronic Back Pain patients – results from the Orion trial
In the IASP 2021 Virtual World Congress of Pain, the results from Orion Corporation’s pilot study ‘VIRPI’ were announced. The novel treatment, a digit…